Escolar Documentos
Profissional Documentos
Cultura Documentos
and superstitions as a
cause of diseases.
Importance of Clinical
History & Examination
Described Fever
Thanks
Monsoon
to Mania
AAFP
S
U
R
I
V
U
R
I
V
E
C
L AN
VE
S
R
O
T
C
E
U
G
A
V
MEDI-NEWS
MEDI-NEWS
MEDI-NEWS
MEDI-NEWS
MEDI-NEWS
MEDI-NEWS
LEPTOSPIROSIS
CHIKUNGUNYA
What is fever ?
Fever is an elevation of
Range
Hypothermia
<36
Normal
37
Mild
38.2-39
Moderate
39 40
High-Grade
40 41.5
Severe
> 41.5
Effects of Fever
For each 1 C elevation of body temp:
Metabolic
rate increases
10-15%
Insensible
300
O2
to 500ml/m2/day
Patterns of Temperature
Continuous fever
Constantly elevated above the normal level
Remittent fever
Fluctuates daily, constantly above normal
Intermittent fever
Daily fluctuation, going below the normal 37C
Relapsing fever
Normal temperature alternate with fever
S OAP
Provisional DAY 1
DAY 2
Subjective
Fever, N V
Objective
101 F
Assessment
Liver +
100 F
Continuous
Liver ++
100 F
Reduced
Liver / Spleen
Plan
CBC MP
Antipyretics
Leucopenia
Cefixime
Blood Culture
Cefixime
DAY 3
Acute
Sub-acute
Chronic
Travel History
Malaria Endemic areas
Dengue fever - eg. Singapore
Epidemic areas
Viral fevers
Typhoid
Schistosomiasis
Tuberculosis hospitals, contact history
Sepsis
TACHYCARDIA
Typhoid fever
Malaria
All fevers
Anemia
Meningitis
Thyrotoxicosis
Leptospirosis
Toxins
Viral
Drug fever
Generalised Lymphadenopathy
Leukaemia - ALL , CLL
Lymphoma Mediastinal Nodes
HIV Oral Candidiasis
Hepatosplenomegaly
Toxoplasma,
Rubella
Disseminated TB
Epitrochlear Nodes
Milliary TB, Lymphoma
HIV, Syphilis
Boil
Abscess Carbuncle
Herpes zooster
Transmitted
Show generalised symptoms
But may target specific organs.
Fatigue, Malaise, Headaches, body
aches and a skin rash with Upper
respiratory symptoms
Require only symptomatic treatment
Some are highly contagious
Viral Diseases
Viral Rash
analgesic drugs.
Bed rest and adequate fluid intake
Nasal decongestants
to severe illness
All age groups
Humans and other animals
Type B
Changes
less rapidly
Milder epidemics
Humans only
Primarily affects children
H1N1
H1N1
Virology or serology?
Virus detection using
Superior to antibody
Rapid virus isolation
determination for
Antigen staining
diagnosis.
Molecular biological
techniques
Detecting Specific
Complementary tool
antibodies
to confirm the
IgG,
diagnosis
IgM
retrospectively.
Anti-viral Treatment
Tamiflu and Relenza, seem to be
effective.
However, the drugs must be
administered at an early stage to be
effective. (Within 2 days)
? Availability, Cost
Swine flu vaccine is developed,
Not yet available with us.
Influenza vaccines
Live Vaccine Not preferred
0.25 ml of the Reconstituted Vaccine
in each nostril.
Inactivate vaccine Best Results
0.5 ml intramuscular
0.25ml for a child (6months to 3
years)
One dose above 9 years
Get vaccinated each year with the
SARS
2003 epidemic of SARS - Corona virus family
The SARS virus may live for up to 6 hours in
To do nothing
is sometimes a good remedy
Hippocrates
u
f
n
o
C
l
l
i
t
?
g
n
i
s
Dengue fever
Most important arbovirus in terms of morbidity,
Flaviviridae
serotype
Transmitted by Aedes
aegypti mosquito
from 3 to 10 days
The Vector
Aedes Egypti
Fresh & clean water breeder
Strong fliers, Day Biter
Their bites are painful
Meal time
8-13
hrs
15 to 17 hrs.
Voracious
appetite
Mosquito Bite
Mosquito inserts its
Dengue - Pathophysiology
Vasculopathy
Increased capillary permeability
High Hematocrit
Abnormal Homeostasis
Thrombocytopenia
You Bleed,
If They Breed
Dengue Illness
DSS
DHF
CLASSICAL DENGUE
BREAKBONE FEVER
UNDIFFERENTIATED
FEBRILE ILLNESS
* With Rash
Clinical features
Primary Infection
Acute febrile illness of sudden onset
Fever lasting 3 to 5 days
Headache, myalgia, arthralgia or muscular
pain, retro-orbital pain, anorexia
Fine maculopapular rash on extremities
Recovery associated with fatigue and
depression
Children usually have milder disease than
adults
40
39
38
Temperature
37
Course of Events
120
Blood Pressure
60
Platelets
38
5
45 52
6
35
9
10
Clinical features
Secondary Infection
90% of cases of DHF and DSS occur in
patients previously infected with the virus
Symptoms are similar to primary infection,
although after a period of 3 to 7 days the
patient has haemorrhagic symptoms
Bleeding, particularly in skin (petechiae),
occasionally in gums and nose
Increased vascular permeability resulting in
leakage of plasma into extravascular spaces
which leads to hypovolaemia
Dengue Presentation
Dengue Presentation
Positive
Tourniquet test
Dengue Presentation
Dengue Presentation
Dengue Presentation
Dengue Presentation
Dengue Presentation
Risk Markers
Very Low Platelet counts
Reduced blood pressure
Vascular changes and coagulopathy
Presence of blood in stools, vomitus,
urine
Circulatory shock
Vomiting and abdominal pain
Lymphadenopathy and hepatomegaly
Primary Infection
Antibodie Appear
s
IgM
5 days
IgG
14 days
Rise
Till
1-3 wks
6 mths
Life
Secondary Infection
Antibodi
es
IgM
IgG
Appear Rise
Titers
May
not
2 days
Very Low
Slow
rise
Higher Titers
Treatment of Dengue
No Specific treatment for primary dengue
Secondary Infection
Intravenous fluid replacement and
Use of plasma expanders
Oxygen therapy
Blood transfusions in cases of severe
bleeding
Chikungunya Symptoms
Incubation 2 to 12 days
Symptoms can persist for several wks.
High fever which can reach 39C, lasts
Diagnosis
1. Four fold rise of HI Antibody
2. IgM capture ELISA - Pune
3. IIFT - Indirect Immuno
Flourescence Test
4. Virus Isolation - Vero BHK21 cell lines
5. Nucleic acid amplification by
PCR & RT- PCR
Differential Diagnosis
Feature
CHIKV
DENGUE
Presentation
A+F+Rash
Arthralgia
Moderate
Severe
Arthritis
Not common
Frequent
Bone pains
None
Thrombocytopenia
May be severe
Hemorrhage
None
May be present
Shock syndrome
Never
May occur
Immunity (IgG)
Life long
Management
No specific treatment for Chikungunya.
Chloroquine and HCQS - possible
Leptospirosis
Mud / Swamp fever
Japanese 7 day fever
Rice Field Fever
Spirochete Jaundice
Canicola Fever
Leptospiral Jaundice
Autumn Fever
Swineherds Disease
Gram -ve
Epidemiology
Difficult to pinpoint the source of infection
Any person can get infected
Rainfall; Water logging
Inadequate drainage facilities
Rodents, cattle & stray dogs
Walking/ working bare foot
Reservoirs of Infection
Leptospira are excreted in the urine
Direct contact - with urine - Through skin
Leptospirosis
Leptospira
Damage
to small
blood vessels
Vasculitis
Clinical Presentation
Types
Clinical Presentation
Common, Mild
< 2% Mortality
Rare, Severe
15% Mortality
1
0
%
Icteric
o
f
C
a
s
e
s
Anicteric
o
f
C
a
s
e
s
9
0
%
Convalescent stage
After fever
Immunopathological
Three signs:
Conjunctival Suffusion
Muscle tenderness
Large lymphonodes
Influenza form
Pneumo-haerrhagic form
Ictero-hemorrhagic form
Meningo-encephalitis
Renal failure form
Sequele of eyes;
Reactive meningitis;
Cerebro arteritis obliterans.
Anicteric Presentation
Leptospiremic Phase
Initial
Immune Phase
Subsequent
Fever, Myalgia
Mild fever
Meningism
Conjunctival suffusion
Uveitis
I.P: 5 to 14 days
Icteric Presentation
Jaundice in 4 to 6 days
Serum Bilirubin increased markedly
SGOT & SGPT Mildly elevated
Hepatocellular Necrosis
Intrahepatic cholestasis
Death Not due to Liver Disease
Renal Leptospirosis
KIDNEYS Mild to Severe
Urinalysis : Hematuria / Pyuria / Proteinuria
Renal Failure: Pre renal azotemia, ATN / AIN
Oliguric / Non Oliguric
Mechanism
Nephrotoxicity
Bacterial
Endotoxin, (Direct )
Hemorrhagic Manifestations
Hemorrhagic Fever - Vascular injury
Respiratory, Alimentary, Renal & Genital tracts
More common in Icteric & with Renal Failure
Hemorrhagic Pneumonitis
Hemoptysis / Respiratory failure
CXR : Single/ Multiple ill defined opacities
Occurs in 2nd week (as early as 24-48 hours)
Laboratory Tests
TC / DC / ESR / Hb / Platelet count
Serum Bilirubin / SGOT/ SGPT
Blood Urea, Creatinine & Electrolytes
Chest X-Ray; ECG
Tests for diagnosis of Leptospirosis
Interpretation of Tests
MAT
ELISA
SAT
Interpretation of Tests
ELISA/SAT
MAT
Interpretation
Positive
Positive
Current Infection
Positive
Negative
Current Infection
Negative
Positive
Past Infection
Negative
Negative
R/o Leptospirosis
Not available
Rising titers
Current Infection
Alb, creatinine
Headache
Rain fall
Fever
Contaminate H20
Temp > 39 F
Animal contact
Conjn. suffusion
15
ELISA IgM + ve
Meningism
15
SAT positive
Muscle pain
15
Jaundice
25
Definite
Culture positive
Treatment
Mild CasesStart Rx. early
Oral Rx 7 to 10 day
IV Rx 5 to 7 days
Ampicillin 1G q.i.d
Ceftriaxone 1G od
Supportive treatment
Cefotaxime 1G t.i.d
Prevention
Difficult due to wild animal infection
Good sanitation, Immunization of live stock
Personal hygiene, PPE, Water treatment
Human vaccines Not Useful
Doxycycline 200 mg weekly for at risk groups
Carry Home
Message
For all of us
Monsoon fevers need extra care
Keep proper clinical assessment (SOAP)
Judicious use of Investigations
Virus Late Diagnosis , Early Treatment?
Choice, Dose, Duration of Antibiotics
Prompt Hospitalization for Risky cases
For all of us
To Avoid Patient Doctor Transmission
To Use Gloves, Masks, Disinfectants
To Discuss with colleagues, be prepared
To Report Infectious Diseases - BMC
To be aware of Antibiotic Resistance
Cure sometimes,
Treat often,
Comfort always - Hippocrates
Mo
y
o
j
En
e
c
i
t
c
a
r
P
n
o
o
ns
Drug fever
DRUG FEVER
All drugs can produce Drug INDUCED fever
except DIGOXIN
Bradycardia, hypotension, Skin rash,
Pruritus, Eosinophilia
Commonest - Pencillin, Sulpha, AKT
Causes
Contamination of the drug
Pharmacologic action of the drug itself
Allergic reaction to the drug
DRUG FEVER
Fever out of proportion to clinical picture
Associated findings:
History of Typhoid
Antonius Musa :
A Roman physician who achieved
fame by treating the Emperor
Augustus 2,000 year ago, with cold
baths when he fell ill with typhoid.
Typhoid Mary
She was the accuse of severe
typhoid outbreaks. Since Mary was
the first Healthy Carrier" of typhoid
fever in the United States.
Typhoid fever
A case of typhoid fever may present as a
disease clinically indistinguishable from
malaria, progress to a bacillary dysentery,
mimic a case of acute bronchitis, simulate
a fully fledged lobar pneumonia, cause an
acute abdomen with perforation, and then
finally in convalescence, with its evil spent,
linger on as an orchitis, a myocarditis or a
peripheral neuritis.
Ronald L. Huckstep, CMG, Hon MD, MA, MD, FRCS, FRACS, FTSE
Bacteriology
Salmonella typhi, Paratyphi A, B, C
Family Enterobacteriaciae ,
70 phage types
Motile gram-negative rods
Antigens
Source of infection
No animal host ,
Source of infection Patient
Carriers : 3 types :
Salmonella
Typhi
2nd Bacteremia
Leucopenia
Pancytopenia
Liver, Spleen,
Gall Bl. BM ,ect
Early acme stage
(1-3Wks
Bacteria In
Gall bladder
IMMUNE
ACTIVATION
LN Proliferate,
Swelling, Necrosis
Intestinal Perforation
Mononuclear
Phagocytes
Peyer's Patches &
Mesenteric Lymph Nodes
In feces
1st Bacteremia
(Incubation stage)
10-14days
All Symptoms
Signs
Defervescence stage
3-4wks
S.Typhi eliminated
Convalescence stage
(4-5wks)
Main Symptoms.
Insidious onset of Generalized
General signs.
Dull expressionless, lethargic face
Flushed cheeks, bright eyes, Toxic look
Rose spots - on the abdomen and chest,
Specific signs.
Respiratory rate - 20-30/min.
Bronchitic chest is a common finding. Vary from
Positive Bl Culture
Rising Widal Titer
Confirmed case
Laboratory Investigations
Normochromic Anemia
WBCs Normal or Reduced
Mild Thrombocytopenia, Subclinical DIC
LFT Mildly elevated
Blood Culture 40 - 90% Positive
IDL Tubex
Typhidot - Better, High negative predictive value
Dipstick test
IgM
IgG
Interpretation
Positive
Negative
Ac. Infection
Positive
Positive
Recent Infection
Negative
Positive
Past / Ac Infection
First Line
Second Line
Chloramphenicol
Fluoroquinolone
Amoxacillin
TMP-SMX
Fluoroquinolone
Azithromycin
Azithromycin
Cefixime
Cefixime
First Line
Second Line
Chloramphenicol
Fluoroquinolone
Amoxacillin
TMP-SMX
Multi-drug
Resistant
Fluoroquinolone
Ceftrioxone
Cefotaxime
Quinolone
Resistance
Ceftrioxone
Cefotaxime
Fluoroquinolone
Dexamethasone Therapy
Short-term, high-dose Corticosteroid
Shock
Altered Sensorium, Delirium, Coma
Vaccination
Vi polysaccharide, is given in a single dose
Protection begins seven days after injection,
Maximum protection being reached 28 days
after injection.
Protective efficacy was 72% one and half
years after vaccination and was still 55%
three years after a single dose.
stomach.
Protection as from 10-14 days after the third
dose.
> 5 years.
Protective efficacy of the enteric-coated capsule
formulation seven years after the last dose is still
62% in areas where the disease is endemic;
Antibiotics should be avoided for seven days
before or after the immunization
Mo
y
o
j
En
e
c
i
t
c
a
r
P
n
o
nso